Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — December 2019

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #994

    https://finance.yahoo.com/news/genmab-ss-cph-gmab-12-064045395.html Lidt lærdom.

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #995

      Genmab i en nøddeskal:
      "After all, when a company has a strong balance sheet, it can often find ways to invest in growth, even if it takes some time".

      1 Reply Last reply
      0
      • Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktørH Offline
        Helge_LarsenPI-redaktør
        wrote on sidst redigeret af
        #996

        Tak for link Solsen.

        1 Reply Last reply
        0
        • Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktørH Offline
          Helge_LarsenPI-redaktør
          wrote on sidst redigeret af
          #997

          Just a moment...

          favicon

          (www.proinvestor.com)

          1 Reply Last reply
          0
          • SolsenS Offline
            SolsenS Offline
            Solsen
            wrote on sidst redigeret af
            #998

            https://www.rigshospitalet.dk/presse-og-nyt/nyheder/nyheder/Sider/2019/december/computermodel-skal-nulstille-kraeftsygdom.aspx Interessant selv om det nok ikke Genmab relateret.

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #999

              Af twitter fremgår at modellen vil få en artikel i nature.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #1000

                a bit more on teprotumumab https://www.fiercebiotech.com/biotech/a-unanimous-vote-fda-panel-greenlights-horizon-s-eye-drug-teprotumumab?utm_source=internal&utm_medium=rss https://www.healio.com/endocrinology/thyroid/news/online/{b02b4c4e-6f26-42bc-8267-74c2021b12dd}/fda-committee-unanimously-recommends-approval-of-teprotumumab-for-thyroid-eye-disease

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #1001

                  this was from DNB, which we saw - Genmab (Hold, TP: DKK1685.00) - Encouraging first data on GEN3013
                  At the ASH conference in Orlando (7–10 December), the focus was on very strong data from J&J’s BCMA CAR-T, JNJ-4528, with 100% ORR and 69% CRR in highly pre-treated patients, which could pose a long-term risk to Darzalex. In addition, we find the early safety and efficacy data on CD3xCD20 (GEN3013) encouraging and have included it in our valuation.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1002

                    Based on the recent strong share price performance, we have downgraded our recommendation to HOLD (BUY) but increased our target price to DKK1,685 (1,630).

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #1003

                      Bryan Garnier - GENMAB - BUY | DKK1600 vs. DKK1550 (+1%)
                      ASH19: R&D day shed the light on DuoBody CD3xCD20

                      Promising data from Genmab’s own bi-spec CD3xCD20
                      Preclinical candidates are on track
                      SC Darzalex should get approval in Q2 next year

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #1004

                        GMAB to be included in NASDAQ Biotechnology Index (Nasdaq:NBI) https://app.researchpool.com/company/ndaq-us6311031081-nasdaq/press/nasdaq-ndaq-annual-changes-to-the-nasdaq-biotechnology-index-1

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #1005

                          Værd at læse:
                          https://www.proinvestor.com/investornyt/651330/langers-skarpe-velkommen-til-fremtidens-planokonomiske-aktiemarked?fbclid=IwAR3JgK6CzNBAOHLXIt082ccZcstQq_7KBdiGaO-SHju5coiWin37EdNaXJk

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #1006

                            Joseph Michael: Griffin standard of care maybe in about a year or less than a year. https://www.youtube.com/watch?v=Oj793HTeFBE

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              MarsFars
                              wrote on sidst redigeret af
                              #1007

                              At genmab kommer i NBI indeks betyder vel at nogle aktører skal ud og købe den ind til deres portefølje? Positivt tænker jeg for aktiekursen

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #1008

                                Timelang række af guldkorn. Hele møllen fra Smoldering til RRMM. Dara i frontline ca. 15 min inde. Især kan anbefales debatten om car-t vs BiTEs ca 32:25 inde. https://www.youtube.com/watch?v=ZhFBUshV6SE

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #1009

                                  Desværre kommer de ikke ind på TAK-079, men ellers bliver stort set alt andet berørt.

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #1010

                                    Tusinde tak Bulder.
                                    https://www.proinvestor.com/index.php?p=debat_1&postid=80153

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #1011

                                      Tak Bulder. Ganske interessant. De mente nok at det var de CAR-T udgaver der blev præsenteret på ash, der havde en fremtid. Men måske second generation - så ikke en dara trussel nu.

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #1012

                                        Interessant at man gerne så korte effektive - knock off your socks - behandlinger. Ikke lange maintenance behandlinger, som patienterne finder besværlige.

                                        1 Reply Last reply
                                        0
                                        • SolsenS Offline
                                          SolsenS Offline
                                          Solsen
                                          wrote on sidst redigeret af
                                          #1013

                                          Jeg er stadig noget i tvivl om, hvor let dara vil erobre first line.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger